Tayar, E., & Kodali, D. (2025). Delayed-onset vitiligo in metastatic HR+/HER2– breast cancer during long-term ribociclib therapy. European Journal of Case Reports in Internal Medicine, 13(1). https://doi.org/10.12890/2025_006043